Skip to main content

Table 2 HPV Prevalence and genotype distribution among various regions of Yunnan province

From: Epidemiologic characterization of human papillomavirus (HPV) infection in various regions of Yunnan Province of China

Variable Overall Central North-east North-west South-east South-west P-Value
(n = 17898) n = 7065 n = 3152 n = 3772 n = 1745 n = 2164
Overalla 14.0 (13.5–14.5 12.9 (12.1–13.7) 11.1 (10.0–12.2) 18.0 (16.8–19.2) 13.3 (11.7–14.9) 19.9 (18.2–21.6) 0.001
High riska 12.2 (–11.7–12.7) 10.5 (9.8–11.2) 9.6 (8.6–10.6) 13.9 (12.0–14.2) 11.6 (10.1–13.1) 18.1 (16.5–19.7) 0.001
Othersa 1.8 (1.6–2.0) 2.4 (2.04–2.7) 1.5 (1.1–1.9) 4.1 (3.5–4.7) 1.7 (1.1–2.3) 1.3 (0.8–1.8) 0.001
Single infectiona 11.0 (10.5–11.4) 10.0 (9.3–10.7) 9.1 (8.1–10.1) 11.3 (10.3–12.3) 10.5 (9.1–11.9) 16.7 ((15.1–18.3) 0.001
Multiple infectiona 3.0 (2.8–3.2) 2.9 (2.5–3.3) 2.0 (1.5–2.5) 4.2 (3.6–4.8) 2.7 (1.9–3.5) 3.1 (2.4–3.8) 0.001
Unidentifieda 1.1 (0.9–1.2) 0.7 (0.5–0.9) 0.8 (0.5–1.1) 2.2 (1.7–2.7) 0.9 (0.5–1.3) 0.9 (0.5–1.3) 0.009
HR-HPV        
 HPV-52a 3.1 (2.9–3.3) 3.4 (3.0–3.8) 2.4 (1.9–2.9) 3.3 (2.7–3.9) 3.0 (2.2–3.8) 3.1 (2.4–3.8) 0.15
 HPV-16a 3.4 (3.1–3.7) 3.0 (2.8–3.2) 2.4 (1.9–2.9) 3.5 (2.9–4.1) 3.4 (2.5–4.2) 5.9 (4.9–6.9) 0.001
 HPV-58a 2.1 (1.9–2.3) 1.9 (1.6–2.2) 1.4 (1.0–1.8) 2.3 (1.8–2.8) 1.5 (0.9–2.1) 3.5 (2.7–4.3) 0.001
 HPV-18a 1.2 (1.0–1.3) 1.1 (0.9–1.3) 1.4 (1.0–1.8) 1.4 (1.0–1.8) 13 (0.7) 1.5 (1.0–2.0) 0.16
 HPV-51 120 (0.7) 49 (0.7) 18 (0.6) 23 (0.6) - 30 (1.4) 0.2
 HPV-39 118 (0.6) 45 (0.6) 13 (0.4) 34 (0.9) 17 (1.0) 9 (0.4) 0.69
 HPV-33 124 (0.7) 44 (0.6) 20 (0.6) 52 (1.4) - 8 (0.4) 0.35
 HPV-68 122 (0.7) 43 (0.6) 19 (0.6) 31 (0.8) 9 (0.5) 20 (0.9)  
 HPV-56 60 (0.3) 32 (0.4) 4 (0.1) 8 (0.2) 8 (0.4) 8 (0.4)  
 HPV-59 56 (0.3) 27 (0.4) 3 (0.1) 19 (0.5) 5 (0.3) 2 (0.09)  
 HPV-31 63 (0.3) 23 (0.3) 9 (0.3) 11 (0.3) 7 (0.4) 13 (0.6)  
 HPV-35 (12) 0.07 7 (0.01) 5 (0.1) - - -  
 HPV-45 12 (0.07) 3 (0.04) 5 (0.1) - 4 (0.2) -  
PHR-HPV        
 HPV-53 176 (1.0) 75 (1.1) 33 (1.0) 32 (0.8) 25 (1.4) 11 (0.5)  
 HPV-81 108 (0.6) 42 (0.6) 12 (0.4) 23 (0.6) 13 (0.7) 18 (0.8)  
 HPV-66   15 (0.2) 9 (0.3) 16 (0.4) 10 (0.6) 18 (0.8)  
LR-HPV        
 HPV-11 68 (0.4) 14 (0.2) - 7 (0.2) 6 (0.3) 5 (0.2)  
 HPV-6 16 (0.09) 9 (0.1) - 4 (0.1) 3 (0.2) -  
 HPV-61 30 (0.2) - 9 (0.3) 5 (0.1) 7 (0.4) 9 (0.4)  
 HPV-43 15 (0.08) 7 (0.1) - - - 8 (0.4)  
 HPV-55 7 (0.04) 6 (0.08) 1 (0.03) - - -  
 HPV-44 12 (0.07) 5 (0.07) - - - 7 (0.3)  
 HPV-42 9 (0.05) 4 (0.06) - - 3 (0.2) 2 (0.09)  
 HPV-40 4 (0.02) - 4 (0.1) - - -  
 HPV-67 1 (0.005) - 1 (0.03) - - -  
 HPV-69 1 (0.005) - 1 (0.03) - - -  
 HPV-70 2 (0.01) 2 (0.03) - - - -  
 HPV-71 3 (0.002) 3 (0.04) - - - -  
 HPV-82 6 (0.03) 1 (0.02) - - 2 (0.1) 3 (0.1)  
 HPV-83 2 (0.01) - - 1 (0.02) - 1 (0.05)  
  1. n number, a95% Confidence interval
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us